ArticleDrug delivery2022

Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis.

Caiwei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.